Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Block and Sugammadex in Laparoscopic Colorectal Surgery
NCT02266056Completed
- Sponsor
- Yonsei University
- Start
- Aug 2014
- Primary completion
- Sep 2015
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium and Sugammadex in colorectal cancer (CRC), sponsored by Yonsei University. Primary endpoint: Intra-abdominal pressure. Started Aug 2014; status: completed.
02
Drugs
rocuroniumSugammadex
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02266056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266056.